Open original FDA record ↗Recall record
- FDA identifier
- Z-2741-2026
- Company in FDA record
- Maquet Cardiovascular, LLC
- FDA classification date
- Jul 15, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its Whippany, NJ facility between March 31 and April 1 of 2026.
Source facts
- Action
- Getinge issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 6/18/2026 via FedEx. The notice explained the issue, risk to health, and requested the following actions be taken: " Immediately identify and quarantine all affected Vasoview Hemopro 2 devices from lot 3000547797. " Do not use affected devices. " If an affected device was used, no further intervention is required. Standard post-operative wound care per facility protocol should be followed. " If any affected devices were transferred within your organization or to another organization, ensure this notice is shared with the appropriate individuals. " Contact Getinge Customer Service 1-888-880-2874 or your Getinge representative to coordinate return of the affected units and replacement product. " Complete and return the enclosed response form to Getinge by e-mailing a copy to recallresponses.qrc@getinge.com.
- Initiated
- 2026-06-02
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states of NY, CA, SC, FL, TX, GA, OR.
- Recall number
- Z-2741-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221161
- FDA classified
- 2026-07-15
- Recall event number
- 99259